MEET THE TEAM
Paul Cloos, PhD
Paul Cloos, PhD
Paul Cloos, PhD
Chief Executive Officer & Co-Founder
Chief Executive Officer & Co-Founder
Background
Paul is a scientist and entrepreneur with over 20 years of experience in drug discovery, translational research and company creation. He co-founded Epitherapeutics, one of Denmark’s first epigenetics start-ups, later acquired by Gilead. At Novo Holdings SeedLab, he leads due diligence and the incubation of early-stage biotech ventures, combining scientific expertise with strategic project leadership and investor engagement.
Paul is a scientist and entrepreneur with over 20 years of experience in drug discovery, translational research and company creation. He co-founded Epitherapeutics, one of Denmark’s first epigenetics start-ups, later acquired by Gilead. At Novo Holdings SeedLab, he leads due diligence and the incubation of early-stage biotech ventures, combining scientific expertise with strategic project leadership and investor engagement.
Paul’s experience spans over 40 scientific publications, 10 patent families and leadership roles in academia, biotech and pharma. He combines deep scientific expertise with strategic insight, having secured multi-million-euro partnerships, advised investors and mentored cross-disciplinary teams. His work drives innovation at the intersection of science and business.
Paul’s experience spans over 40 scientific publications, 10 patent families and leadership roles in academia, biotech and pharma. He combines deep scientific expertise with strategic insight, having secured multi-million-euro partnerships, advised investors and mentored cross-disciplinary teams. His work drives innovation at the intersection of science and business.